Congratulations Rebecca Gladdy, recipient of a 2021 100% Fund Seed Grant targeting Rhabdomyosarcoma!
Rebecca Gladdy’s grant entitled “Hunting for therapeutic targets in Rhabdomyosarcoma: Comparative proteomics in cross-species model systems for precision diagnostics and rapid drug testing” has been selected by the C17 Research Network for funding in the 2021 100% Fund Seed Grant Competition.
This study is funded by the C17 Council Research Network through collaboration and financial support from Fight Like Mason, Great Cycle Challenge, and Childhood Cancer Canada.
Dr. Gladdy is a Clinician Scientist and Associate Professor at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System (Toronto).